Verano Holdings Corp. (VRNO.NE)

CAD 1.78

(-4.81%)

EBITDA Summary of Verano Holdings Corp.

Verano Holdings Corp.'s latest annual EBITDA in 2023 was 239.21 Million USD , up 41.01% from previous year.
Verano Holdings Corp.'s latest quarterly EBITDA in 2024 Q2 was 65.68 Million USD , up 3.92% from previous quarter.
Verano Holdings Corp. reported an annual EBITDA of 47.32 Million USD in 2022, up 44.01% from previous year.
Verano Holdings Corp. reported an annual EBITDA of 212.51 Million CAD in 2021, up 45.88% from previous year.
Verano Holdings Corp. reported a quarterly EBITDA of 82.47 Million USD for 2024 Q1, up 201.14% from previous quarter.
Verano Holdings Corp. reported a quarterly EBITDA of N/A for 2023 FY, up 41.01% from previous quarter.

Annual EBITDA Chart of Verano Holdings Corp. (2023 - 2017)

Historical Annual EBITDA of Verano Holdings Corp. (2023 - 2017)

Year	EBITDA	EBITDA Growth
2023	239.21 Million USD	41.01%
2022	47.32 Million USD	44.01%
2021	212.51 Million CAD	45.88%
2020	134.36 Million USD	177567.72%
2019	-75.71 Thousand CAD	44.71%
2018	-136.93 Thousand CAD	-83.85%
2017	-1.26 Million CAD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	65.68 Million USD	3.92%
2024 Q1	82.47 Million USD	201.14%
2023 FY	- USD	41.01%
2023 Q2	91.79 Million USD	-5.22%
2023 Q3	113.75 Million USD	23.92%
2023 Q1	96.85 Million USD	15.69%
2023 Q4	95.52 Million USD	-16.02%
2022 FY	- USD	44.01%
2022 Q4	83.71 Million CAD	-19.95%
2022 Q3	104.58 Million CAD	145.74%
2022 Q2	42.55 Million CAD	-22.74%
2022 Q1	55.08 Million CAD	-41.41%
2021 Q3	54.97 Million CAD	0.0%
2021 FY	- CAD	45.88%
2021 Q4	94.02 Million CAD	71.02%
2020 FY	- USD	177567.72%
2019 FY	- CAD	44.71%
2018 FY	- CAD	-83.85%
2017 FY	- CAD	0.0%

Peer EBITDA Comparison of Verano Holdings Corp.

Name	EBITDA	EBITDA Difference
Filament Health Corp.	-4.66 Million CAD	5222.741%